PLCB3 and myeloproliferative neoplasm: Our previous study demonstrated that retroviral expression of PLC-β3-CT in PLC-β3-deficient CD34−c-Kit+Sca-1+Lin− cells (enriched in long-term HSCs [26]) inhibits the development of MPN when transplanted into lethally irradiated mice [16].